Study types
- article 3
Frequent coauthors
article
2011
BACKGROUND: Thrombocytopenia is a common hematologic disorder observed in patients with chronic hepatitis C virus (HCV) infection. Combined peginterferon (PEG-INF) and ribavirin treatment may exacerbate thrombocytopenia in patients with HCV…
article
2010
The aim of this study was to assess the effectiveness of danazol in thrombocytopenia associated with the use of peg‐interferon alfa2a y ribavirin (IFN + RIBA) in patients with chronic hepatitis C (HCV). A clinical trial open, prospective, w…
article
2007
The current standard therapy of patients with chronic hepatitis C is the combination of peg‐interferon (IFN)‐α and ribavirin.However, it is well known that interferon in combination with ribavirin treatment may exacerbate the neutropenia an…